Skip to content

AMIStem-H Radiological Assessment

Etude rétrospective et Prospective, Multicentrique, Non contrôlée, Non randomisée, Ouverte évaluant la Performance et la sécurité de l'Implant AMIStem

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03505580
Enrollment
500
Registered
2018-04-23
Start date
2013-10-31
Completion date
2025-08-31
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Replacement Arthroplasty

Brief summary

The purpose of this study is to evaluate radiological performance of the cementless femoral stem AMIStem H at 1 and 5-year follow-up. All the patients operated at the investigational sites between April 2009 and April 2012 will be reviewed at 1, 5 and 10 year according to standard practice

Interventions

None listed

Sponsors

Medacta International SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patients who underwent total hip arthroplasty at the investigational sites between April 2009 and April 2012 * patients bearing an AMIStem-H cementless femoral stem

Exclusion criteria

* patients who refuse to give consent for the treatment of data

Design outcomes

Primary

MeasureTime frame
Presence of radiolucencies5 years

Secondary

MeasureTime frame
correlation between the presence of radiolucencies and patient/implant characteristics5 years, 10 years
evaluation of radiolucent lines progression1 years, 10 years
Record of adverse events1, 5 years and 10 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026